相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Statin Therapy and Mortality in HIV-Infected Individuals; A Danish Nationwide Population-Based Cohort Study
Line D. Rasmussen et al.
PLOS ONE (2013)
Matrix Stiffness Modulates Proliferation, Chemotherapeutic Response, and Dormancy in Hepatocellular Carcinoma Cells
Joerg Schrader et al.
HEPATOLOGY (2011)
Hepatitis C virus resistance to protease inhibitors
Philippe Halfon et al.
JOURNAL OF HEPATOLOGY (2011)
Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection
Kenneth E. Sherman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The Heme Oxygenase 1 Product Biliverdin Interferes with Hepatitis C Virus Replication by Increasing Antiviral Interferon Response
Elisabeth Lehmann et al.
HEPATOLOGY (2010)
Efficacy and Safety of Peginterferon Alfa-2a (40KD) Plus Ribavirin in Hepatitis C Patients with Advanced Fibrosis and Cirrhosis
Savino Bruno et al.
HEPATOLOGY (2010)
Biliverdin Inhibits Hepatitis C Virus Nonstructural 3/4A Protease Activity: Mechanism for the Antiviral Effects of Heme Oxygenase?
Zhaowen Zhu et al.
HEPATOLOGY (2010)
Fluvastatin as an adjuvant to pegylated interferon and ribavirin in HIV/hepatitis C virus genotype 1 co-infected patients: an open-label randomized controlled study
Laura Milazzo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Cellular and molecular biology of HCV infection and hepatitis
Hengli Tang et al.
CLINICAL SCIENCE (2009)
Evaluation of the efficacy and safety of a statin/caffeine combination against H5N1, H3N2 and H1N1 virus infection in BALB/c mice
Zeyu Liu et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Statins Potentiate the In Vitro Anti-Hepatitis C Virus Activity of Selective Hepatitis C Virus Inhibitors and Delay or Prevent Resistance Development
Leen Delang et al.
HEPATOLOGY (2009)
An Open Pilot Study Exploring the Efficacy of Fluvastatin, Pegylated Interferon and Ribavirin in Patients with Hepatitis C Virus Genotype 1b in High Viral Loads
Hitomi Sezaki et al.
INTERVIROLOGY (2009)
Do statins reduce hepatitis C RNA titers during routine clinical use?
Kimberly A. Forde et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Fluvastatin inhibits hepatitis C replication in humans
Ted Bader et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Hepatitis C Virus Infection and Hepatocellular Carcinoma
Wojciech Blonski et al.
CLINICS IN LIVER DISEASE (2008)
Statin-induced inhibition of HIV-1 release from latently infected U1 cells reveals a critical role for protein prenylation in HIV-1 replication
Tohti Amet et al.
MICROBES AND INFECTION (2008)
Reciprocal effects of Micro-RNA-122 on expression of heme oxygenase-1 and hepatitis C virus genes in human hepatocytes
Ying Shan et al.
GASTROENTEROLOGY (2007)
Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets
Panagiotis A. Konstantinopoulos et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Identification of determinants involved in initiation of hepatitis C virus RNA synthesis by using intergenotypic replicase chimerase
Marco Binder et al.
JOURNAL OF VIROLOGY (2007)
Atorvastatin does not exhibit antiviral activity against HCV at conventional doses: A pilot clinical trial
Jacqueline G. O'Leary et al.
HEPATOLOGY (2007)
Statins attenuate ischemia-reperfusion injury by inducing heme oxygenase-1 in infiltrating macrophages
Faikah Gueler et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0
Roger D. Everett et al.
JOURNAL OF VIROLOGY (2006)
Different anti-HCV profiles of statins and their potential for combination therapy with interferon
Masanori Ikeda et al.
HEPATOLOGY (2006)
Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras
Thomas Pietschmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen
J Moffat et al.
CELL (2006)
Simvastatin induces heme oxygenase-1 - A novel mechanism of vessel protection
TS Lee et al.
CIRCULATION (2004)
The antioxidant defense protein heme oxygenase 1 is a novel target for statins in endothelial cells
N Grosser et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Role of Bach-1 in regulation of heme oxygenase-1 in human liver cells - Insights from studies with small interfering RNAs
Y Shan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Substrate compliance versus ligand density in cell on gel responses
A Engler et al.
BIOPHYSICAL JOURNAL (2004)
Statin compounds reduce human immunodeficiency virus type 1 replication by preventing the interaction between virion-associated host intercellular adhesion molecule 1 and its natural cell surface ligand LFA-1
JF Giguère et al.
JOURNAL OF VIROLOGY (2004)
Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation
J Ye et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Hepatitis C virus RNA replication is resistant to tumour necrosis factor-α
M Frese et al.
JOURNAL OF GENERAL VIROLOGY (2003)
Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors
D Williams et al.
CLINICAL PHARMACOKINETICS (2002)
分享论文
